KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis
Europe - AMS:PHIA - NL0000009538 - Common Stock
24.74 EUR
+0.31 (+1.27%)
Taking everything into account, PHIA scores 3 out of 10 in our fundamental rating. PHIA was compared to 60 industry peers in the Health Care Equipment & Supplies industry. PHIA has a bad profitability rating. Also its financial health evaluation is rather negative. PHIA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year PHIA was profitable.
PHIA had a positive operating cash flow in the past year.
In multiple years PHIA reported negative net income over the last 5 years.
PHIA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
PHIA's Return On Assets of 0.61% is on the low side compared to the rest of the industry. PHIA is outperformed by 61.67% of its industry peers.
With a Return On Equity value of 1.56%, PHIA is not doing good in the industry: 61.67% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 4.27%, PHIA is in line with its industry, outperforming 43.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROIC | 4.27% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHIA has a Profit Margin of 0.91%. This is in the lower half of the industry: PHIA underperforms 61.67% of its industry peers.
PHIA has a Operating Margin of 6.11%. This is comparable to the rest of the industry: PHIA outperforms 45.00% of its industry peers.
PHIA's Operating Margin has declined in the last couple of years.
PHIA's Gross Margin of 43.85% is on the low side compared to the rest of the industry. PHIA is outperformed by 70.00% of its industry peers.
In the last couple of years the Gross Margin of PHIA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
PHIA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for PHIA has been reduced compared to 1 year ago.
PHIA has more shares outstanding than it did 5 years ago.
PHIA has a worse debt/assets ratio than last year.
2.2 Solvency
PHIA has an Altman-Z score of 1.94. This is not the best score and indicates that PHIA is in the grey zone with still only limited risk for bankruptcy at the moment.
PHIA has a Altman-Z score (1.94) which is in line with its industry peers.
The Debt to FCF ratio of PHIA is 19.41, which is on the high side as it means it would take PHIA, 19.41 years of fcf income to pay off all of its debts.
PHIA has a Debt to FCF ratio (19.41) which is comparable to the rest of the industry.
PHIA has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.69, PHIA is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Altman-Z | 1.94 |
ROIC/WACC0.67
WACC6.36%
2.3 Liquidity
PHIA has a Current Ratio of 1.26. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.26, PHIA is not doing good in the industry: 63.33% of the companies in the same industry are doing better.
A Quick Ratio of 0.81 indicates that PHIA may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.81, PHIA is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 12.16% over the past year.
The Earnings Per Share has been decreasing by -7.17% on average over the past years.
The Revenue has decreased by -0.81% in the past year.
Measured over the past years, PHIA shows a small growth in Revenue. The Revenue has been growing by 1.00% on average per year.
EPS 1Y (TTM)12.16%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%0.5%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.14%
3.2 Future
The Earnings Per Share is expected to grow by 12.68% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.65% on average over the next years.
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
PHIA is valuated rather expensively with a Price/Earnings ratio of 17.18.
Based on the Price/Earnings ratio, PHIA is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.28, PHIA is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 16.17, the valuation of PHIA can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PHIA indicates a somewhat cheap valuation: PHIA is cheaper than 70.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 33.61. PHIA is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.18 | ||
| Fwd PE | 16.17 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHIA indicates a somewhat cheap valuation: PHIA is cheaper than 71.67% of the companies listed in the same industry.
PHIA's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 54.89 | ||
| EV/EBITDA | 12.63 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHIA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)72.31
PEG (5Y)N/A
EPS Next 2Y5.1%
EPS Next 3Y7.59%
5. Dividend
5.1 Amount
PHIA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMS:PHIA (11/11/2025, 3:23:10 PM)
24.74
+0.31 (+1.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners47.54%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap23.82B
Revenue(TTM)18.02B
Net Income(TTM)162.00M
Analysts74.81
Price Target27.39 (10.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)0.42%
PT rev (3m)5.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.41%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)-8.83%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-0.85%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-1.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.18 | ||
| Fwd PE | 16.17 | ||
| P/S | 1.33 | ||
| P/FCF | 54.89 | ||
| P/OCF | 21.68 | ||
| P/B | 2.3 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.63 |
EPS(TTM)1.44
EY5.82%
EPS(NY)1.53
Fwd EY6.19%
FCF(TTM)0.45
FCFY1.82%
OCF(TTM)1.14
OCFY4.61%
SpS18.54
BVpS10.78
TBVpS-1.76
PEG (NY)72.31
PEG (5Y)N/A
Graham Number18.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROCE | 5.69% | ||
| ROIC | 4.27% | ||
| ROICexc | 4.72% | ||
| ROICexgc | 15.5% | ||
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% | ||
| FCFM | 2.43% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Debt/EBITDA | 3.01 | ||
| Cap/Depr | 51.35% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 4 | ||
| Cash Conversion | 46.06% | ||
| Profit Quality | 267.9% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 1.94 |
F-Score8
WACC6.36%
ROIC/WACC0.67
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.16%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%0.5%
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.14%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.14%
EBIT Next 3Y21.01%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%
KONINKLIJKE PHILIPS NV / PHIA.AS FAQ
Can you provide the ChartMill fundamental rating for KONINKLIJKE PHILIPS NV?
ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS.
Can you provide the valuation status for KONINKLIJKE PHILIPS NV?
ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHIA.AS). This can be considered as Fairly Valued.
Can you provide the profitability details for KONINKLIJKE PHILIPS NV?
KONINKLIJKE PHILIPS NV (PHIA.AS) has a profitability rating of 2 / 10.
How financially healthy is KONINKLIJKE PHILIPS NV?
The financial health rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 2 / 10.
What is the expected EPS growth for KONINKLIJKE PHILIPS NV (PHIA.AS) stock?
The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NV (PHIA.AS) is expected to grow by 0.24% in the next year.